Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > W Mark Hahn > Profile

W Mark Hahn

Affiliations

  • Chief Financial Officer at Verona Pharma Plc (VRNA), 2024-02-05
  • Director at Alsp Orchid Acquisition Corp I (ALOR), 2021-11-18
  • Chief Financial Officer at Dova Pharmaceuticals Inc. (DOVA), 2019-11-12
  • Evp And Cfo at Cempra Inc. (CEMP), 2017-02-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Dova Pharmaceuticals Inc.
 DOVA $6.28 2,500 Officer 2,500 2018-12-19 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Verona Pharma Plc
 VRNA $2.47 8,616 Officer 15,521,248 2023-08-07 Filing
Verona Pharma Plc
 VRNA $2.50 150,000 Officer 15,529,864 2023-08-04 Filing
Verona Pharma Plc
 VRNA $2.54 117,272 Officer 15,679,864 2023-08-03 Filing
Verona Pharma Plc
 VRNA $2.59 73,704 Officer 15,797,136 2023-08-02 Filing
Verona Pharma Plc
 VRNA $2.68 105,944 Officer 15,870,840 2023-08-01 Filing